-

Arlington Capital Partners Forms GRVTY, Defense Technology Company

New platform delivers leading edge solutions to address top national security priorities

ARLINGTON, Va.--(BUSINESS WIRE)--Arlington Capital Partners, (“Arlington”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced the formation of GRVTY, a next generation leader in defense technology solutions for national security priorities across the Department of Defense, Intelligence Community and Homeland Security.

GRVTY supports the U.S. government’s growing intelligence, surveillance, reconnaissance and targeting (ISR&T) challenges with advanced capabilities in geospatial intelligence (GEOINT), signals intelligence (SIGINT) and cyber combined with proven expertise to solve complex national security mission challenges. The company is led by CEO Katie Selbe, who has held senior leadership roles at two prior Arlington portfolio companies.

“At a time when the country is facing an increasingly complex national security environment, it is more important than ever for decisionmakers to receive rapid and trusted intelligence and analysis,” said Katie Selbe, CEO of GRVTY. “GRVTY was created to deliver American dominance from outer space to cyberspace, and I look forward to delivering critical situational awareness to support our customers’ national security missions.”

“GRVTY will deliver innovation at speed and scale to support our national security customers,” said David Wodlinger, a Managing Partner at Arlington Capital Partners. “We plan to provide significant resources to GRVTY as it grows rapidly to become the next major defense technology company.”

GRVTY has over 325 employees across eleven states with primary locations including Arlington, Va., Annapolis Junction, Md., Dulles, Va., Chantilly, Va., Springfield, Va. and St. Louis and has more than $100 million in revenue.

About GRVTY

GRVTY is a defense technology company. Our automated ISR&T platforms, software and data solutions help our defense, intelligence and homeland security customers turn insight into action faster and with confidence. Every day, our dedicated employees answer the challenge to rapidly deliver mission and technical expertise to keep America safe and secure. Learn more at www.grvty.com and follow us on LinkedIn.

About Arlington Capital Partners

Arlington Capital Partners is a Washington, D.C.-area private investment firm specializing in government regulated industries. The firm partners with founders and management teams to build strategically important businesses in the government services and technology, aerospace and defense, and healthcare sectors. Since its inception in 1999, Arlington has invested in over 175 companies and is currently investing out of its $3.8 billion Fund VI. For more information, visit Arlington's website at www.arlingtoncap.com and follow Arlington on LinkedIn.

Contacts

Media
GRVTY:
Ben Ingham
Vice President, Marketing and Communications
bingham@grvty.com

Arlington Capital Partners:
Meredith Bishop
Prosek Partners
Pro-arlington@prosek.com

Arlington Capital Partners


Release Versions

Contacts

Media
GRVTY:
Ben Ingham
Vice President, Marketing and Communications
bingham@grvty.com

Arlington Capital Partners:
Meredith Bishop
Prosek Partners
Pro-arlington@prosek.com

More News From Arlington Capital Partners

Highwater Bolsters its Leadership Team with Three Seasoned Hires

PORTLAND, Ore.--(BUSINESS WIRE)--Highwater (the “Company”), a leading provider of naval services to the U.S., Australian, and Allied navies, today announced the appointments of Dave Whitcomb as Chief Operating Officer and Scott McMurtry as Chief Financial Officer of Highwater, and Andy Davis as Chief Executive Officer of Highwater Australia. All three executives will report to Steve Zogas, Highwater’s global CEO. Highwater is a portfolio company of Arlington Capital Partners, a Washington, D.C....

AVS Bio, an Arlington Capital Partners Portfolio Company, Acquires Biorbyt Ltd.

NORWICH, Conn.--(BUSINESS WIRE)--AVS Bio (the “Company”), a leading global provider of critical inputs and services for the bioprocessing and biologics industries, today announced it has acquired Biorbyt Ltd. (“Biorbyt”), a global supplier of high-quality bio-reagents, antibodies, proteins, and other biomaterials for life science research. The acquisition significantly expands AVS Bio’s catalog of research products and global distribution capabilities through Biorbyt’s advanced ecommerce platfo...

Everest Clinical Research Expands Global Biometrics Capabilities with Acquisition of Firma Clinical Research's Data Services Business Unit

TORONTO--(BUSINESS WIRE)--Everest Clinical Research (“Everest”), a data-first, full-service clinical research organization, today announced the acquisition of the Biometrics and Data Services business unit of Firma Clinical Research (“Firma DS”), expanding Everest's global biometrics expertise and clinical data science capabilities. Everest is a portfolio company of Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private equity firm with extensive experience investing in regul...
Back to Newsroom